Recombinant Human LR3-IGF-1
產(chǎn)品名稱: Recombinant Human LR3-IGF-1
英文名稱:
產(chǎn)品編號(hào): C023
產(chǎn)品價(jià)格: 0
產(chǎn)品產(chǎn)地: 中國(guó)
品牌商標(biāo): Novoprotein
更新時(shí)間: null
使用范圍: null
生物谷
- 聯(lián)系人 : 請(qǐng)聯(lián)系郵箱
- 地址 : 上海市徐匯區(qū)光啟城辦公樓3樓
- 郵編 : 100176
- 所在區(qū)域 : 上海
- 電話 : business@bioon.com 點(diǎn)擊查看
- 傳真 : 點(diǎn)擊查看
- 郵箱 : business@bioon.com
Insulin-like growth factor I (IGF1) belongs to the family of insulin-like growth factors that are structurally homologous to proinsulin. Mature IGFs are generated by proteolytic processing of inactive precursor proteins, which contains the N- and C-terminal propeptide regions. Mature human IGF-I consisting of 70 amino acids has 94% identity with mouse IGF-I and exhibits cross-species activity. IGF-1 binds IGF-IR, IGF-IIR, and the insulin receptor and plays a key role in cell cycle progression, cell proliferation and tumor progression. IGF-1 expression is regulated by growth hormone. R3 IGF-1 is an 83 amino acid analog of IGF-1 comprising the complete human IGF-1 sequence with the substitution of an Arg (R) for the Glu(E) at position three, hence R3, and a 13 amino acid extension peptide at the N terminus. R3 IGF-1 has been produced with the purpose of increasing biological activity. R3 IGF-1 is significantly more potent than human IGF-I in vitro.
